Cargando…
Comparative Effectiveness of Prophylactic Therapies for Necrotizing Enterocolitis in Preterm Infants: Protocol for a Network Meta-analysis of Randomized Trials
Necrotizing enterocolitis (NEC) is a common and devastating disease with high morbidity and mortality in premature infants. Current literature on the prevention of NEC has limitations including lack of direct and indirect comparisons of available therapies. We will search MEDLINE, EMBASE, Science Ci...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151977/ https://www.ncbi.nlm.nih.gov/pubmed/30283615 http://dx.doi.org/10.4103/ijpvm.IJPVM_328_17 |
_version_ | 1783357267041583104 |
---|---|
author | Sadeghirad, Behnam Florez, Ivan D. Chang, Yaping Forutan, Farid Zeraatkar, Dena Morgan, Rebecca L. Shahid, Shaneela Bala, Malgorzata M. Beyene, Joseph Offringa, Martin Adams-Webber, Thomasin Sherman, Philip M. El-Gouhary, Enas Guyatt, Gordon H. Johnston, Bradley C. |
author_facet | Sadeghirad, Behnam Florez, Ivan D. Chang, Yaping Forutan, Farid Zeraatkar, Dena Morgan, Rebecca L. Shahid, Shaneela Bala, Malgorzata M. Beyene, Joseph Offringa, Martin Adams-Webber, Thomasin Sherman, Philip M. El-Gouhary, Enas Guyatt, Gordon H. Johnston, Bradley C. |
author_sort | Sadeghirad, Behnam |
collection | PubMed |
description | Necrotizing enterocolitis (NEC) is a common and devastating disease with high morbidity and mortality in premature infants. Current literature on the prevention of NEC has limitations including lack of direct and indirect comparisons of available therapies. We will search MEDLINE, EMBASE, Science Citation Index Expanded, Social Sciences Citation Index, CINAHL, Scopus, ProQuest Dissertations and Theses database, and grey literature sources to identify eligible trials evaluating NEC preventive therapies. Eligible studies will (1) enroll preterm (gestational age <37 weeks) and/or low birth weight (birth weight <2500 g) infants, (2) randomize infants to any preventive intervention or a placebo, or alternative active or nonactive intervention. Our outcomes of interest are severe NEC (stage II or more, based on Bell's criteria), all-cause mortality, NEC-related mortality, late-onset sepsis, duration of hospitalization, weight gain, time to establish full enteral feeds, and treatment-related adverse events. Two reviewers will independently screen trials for eligibility, assess risk of bias, and extract data. All discrepancies will be resolved by discussion. We will specify a priori explanations for heterogeneity between studies. For available comparisons between treatment and no treatment, and direct comparisons of treatments, we will conduct conventional meta-analysis using a random effects model. We will conduct a network meta-analysis using a random effects model within the Bayesian framework using Markov chain Monte Carlo methods to assess relative effects of eligible interventions. We will assess the certainty in direct, indirect, and network estimates using the Grading of Recommendations Assessment, Development and Evaluation approach. ETHICS AND DISSEMINATION: We will disseminate our findings through a peer-reviewed publication and conference presentations. |
format | Online Article Text |
id | pubmed-6151977 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-61519772018-10-03 Comparative Effectiveness of Prophylactic Therapies for Necrotizing Enterocolitis in Preterm Infants: Protocol for a Network Meta-analysis of Randomized Trials Sadeghirad, Behnam Florez, Ivan D. Chang, Yaping Forutan, Farid Zeraatkar, Dena Morgan, Rebecca L. Shahid, Shaneela Bala, Malgorzata M. Beyene, Joseph Offringa, Martin Adams-Webber, Thomasin Sherman, Philip M. El-Gouhary, Enas Guyatt, Gordon H. Johnston, Bradley C. Int J Prev Med Review Protocol Necrotizing enterocolitis (NEC) is a common and devastating disease with high morbidity and mortality in premature infants. Current literature on the prevention of NEC has limitations including lack of direct and indirect comparisons of available therapies. We will search MEDLINE, EMBASE, Science Citation Index Expanded, Social Sciences Citation Index, CINAHL, Scopus, ProQuest Dissertations and Theses database, and grey literature sources to identify eligible trials evaluating NEC preventive therapies. Eligible studies will (1) enroll preterm (gestational age <37 weeks) and/or low birth weight (birth weight <2500 g) infants, (2) randomize infants to any preventive intervention or a placebo, or alternative active or nonactive intervention. Our outcomes of interest are severe NEC (stage II or more, based on Bell's criteria), all-cause mortality, NEC-related mortality, late-onset sepsis, duration of hospitalization, weight gain, time to establish full enteral feeds, and treatment-related adverse events. Two reviewers will independently screen trials for eligibility, assess risk of bias, and extract data. All discrepancies will be resolved by discussion. We will specify a priori explanations for heterogeneity between studies. For available comparisons between treatment and no treatment, and direct comparisons of treatments, we will conduct conventional meta-analysis using a random effects model. We will conduct a network meta-analysis using a random effects model within the Bayesian framework using Markov chain Monte Carlo methods to assess relative effects of eligible interventions. We will assess the certainty in direct, indirect, and network estimates using the Grading of Recommendations Assessment, Development and Evaluation approach. ETHICS AND DISSEMINATION: We will disseminate our findings through a peer-reviewed publication and conference presentations. Medknow Publications & Media Pvt Ltd 2018-09-17 /pmc/articles/PMC6151977/ /pubmed/30283615 http://dx.doi.org/10.4103/ijpvm.IJPVM_328_17 Text en Copyright: © 2018 International Journal of Preventive Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Protocol Sadeghirad, Behnam Florez, Ivan D. Chang, Yaping Forutan, Farid Zeraatkar, Dena Morgan, Rebecca L. Shahid, Shaneela Bala, Malgorzata M. Beyene, Joseph Offringa, Martin Adams-Webber, Thomasin Sherman, Philip M. El-Gouhary, Enas Guyatt, Gordon H. Johnston, Bradley C. Comparative Effectiveness of Prophylactic Therapies for Necrotizing Enterocolitis in Preterm Infants: Protocol for a Network Meta-analysis of Randomized Trials |
title | Comparative Effectiveness of Prophylactic Therapies for Necrotizing Enterocolitis in Preterm Infants: Protocol for a Network Meta-analysis of Randomized Trials |
title_full | Comparative Effectiveness of Prophylactic Therapies for Necrotizing Enterocolitis in Preterm Infants: Protocol for a Network Meta-analysis of Randomized Trials |
title_fullStr | Comparative Effectiveness of Prophylactic Therapies for Necrotizing Enterocolitis in Preterm Infants: Protocol for a Network Meta-analysis of Randomized Trials |
title_full_unstemmed | Comparative Effectiveness of Prophylactic Therapies for Necrotizing Enterocolitis in Preterm Infants: Protocol for a Network Meta-analysis of Randomized Trials |
title_short | Comparative Effectiveness of Prophylactic Therapies for Necrotizing Enterocolitis in Preterm Infants: Protocol for a Network Meta-analysis of Randomized Trials |
title_sort | comparative effectiveness of prophylactic therapies for necrotizing enterocolitis in preterm infants: protocol for a network meta-analysis of randomized trials |
topic | Review Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151977/ https://www.ncbi.nlm.nih.gov/pubmed/30283615 http://dx.doi.org/10.4103/ijpvm.IJPVM_328_17 |
work_keys_str_mv | AT sadeghiradbehnam comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials AT florezivand comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials AT changyaping comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials AT forutanfarid comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials AT zeraatkardena comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials AT morganrebeccal comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials AT shahidshaneela comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials AT balamalgorzatam comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials AT beyenejoseph comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials AT offringamartin comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials AT adamswebberthomasin comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials AT shermanphilipm comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials AT elgouharyenas comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials AT guyattgordonh comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials AT johnstonbradleyc comparativeeffectivenessofprophylactictherapiesfornecrotizingenterocolitisinpreterminfantsprotocolforanetworkmetaanalysisofrandomizedtrials |